WallStreetZenWallStreetZen

NASDAQ: STLN
Starling Oncology Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Starling Oncology revenue was $587.24M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $161.3M, up 9.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, STLN annual revenue was $502.7M, with 27.8% growth year-over-year.

STLN past revenue growth

How has STLN's revenue growth performed historically?

Company
38.38%
Industry
9.05%
Market
40.28%
STLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
STLN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

STLN revenue history

Current Revenue
$587.2M
Current Earnings
-$40.8M
Current Profit Margin
-7%

Be the first to know when STLN announces revenue.

STLN Revenue History By Year

STLN Yearly RevenueSTLN RevenueSTLN ChangeSTLN Revenue Growth
2025-12-31$502.73M$109.32M+27.79%
2024-12-31$393.41M$69.17M+21.33%
2023-12-31$324.24M$71.76M+28.42%
2022-12-31$252.48M$49.48M+24.37%
2021-12-31$203.00M$15.49M+8.26%
2020-12-31$187.52M$32.11M+20.66%
2019-12-31$155.41MN/AN/A

1 of 1

Starling Oncology Revenue FAQ

What was STLN's revenue last quarter?

On Aug 6, 2026, Starling Oncology (NASDAQ: STLN) reported Q2 2026 revenue of $161.28 million up 34.62% year over year. In the same quarter last year, Starling Oncology's revenue was $119.80 million.

What was Starling Oncology's revenue in 2025?

Starling Oncology's annual revenue for the twelve months ending Dec 31, 2025 was $502.73 million, a 27.79% increase year over year.

How much does Starling Oncology make in a day?

Based on Starling Oncology annual revenue for the past five years, STLN makes an average of $918,282.74 per day.

What was Starling Oncology's annual revenue growth in the past year?

As of Q3 2026, Starling Oncology's revenue has grown 38.38% year over year. This is 29.33 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 9.05%. Starling Oncology's revenue in the past year totaled $587.24 million.

How much does Starling Oncology make in a year?

Starling Oncology's revenue by year for the past five years is:
  • Starling Oncology's revenue for the twelve months ending Dec 31, 2025 was $502.73 million, a 27.79% increase year over year.
  • Starling Oncology's annual revenue for Dec 31, 2024 was $393.41 million, a 21.33% increase from 2023.
  • Starling Oncology's annual revenue for 2023 was $324.24 million, a 28.42% increase from 2022.
  • Starling Oncology's annual revenue for 2022 was $252.48 million, a 24.37% increase from 2021.
  • Starling Oncology's annual revenue for 2021 was $203.00 million, a 8.26% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.